31 Mar 2023
Assets374.06
Total Income262.70
EBITDA56.31
Profit After Tax-2.11
NET Worth62.88
Reserves and Surplus36.05
Total Borrowing215.66
Open 1st Sep 2025 · Close 3rd Sep 2025 · Listing 9th Sep 2025
The shares listed at ₹135.00, a 7.14% move from the issue price. Amanta Healthcare is a Mainboard IPO with an issue size of ₹126.00 crore, proposed for listing on BSE, NSE. The offer opens on 1st Sep 2025 and closes on 3rd Sep 2025. The issue structure includes a fresh issue of ₹126.00 crore. The current listing schedule points to 9th Sep 2025.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 119 | ₹14,994 |
| Object | Amount |
|---|---|
| Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat | ₹70.00 Cr |
| Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat | ₹30.13 Cr |
| General Corporate Purposes | ₹6.60 Cr |
| Issue Expenses | ₹19.26 Cr |
| Total | ₹126.00 Cr |
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 12.42% |
| ROCE | 13.72% |
| Debt / Equity | 2.02% |
| RoNW | 10.89% |
| PAT Margin | 3.86% |
| EBITDA Margin | 22.11% |
| Price to Book Value | 3.77 |
| Expense | Amount |
|---|---|
| Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat | ₹70.00 Cr |
| Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat | ₹30.13 Cr |
| General Corporate Purposes | ₹6.60 Cr |
| Issue Expenses | ₹19.26 Cr |
| Total | ₹126.00 Cr |